AT365926B - Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen - Google Patents

Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen

Info

Publication number
AT365926B
AT365926B AT0363479A AT363479A AT365926B AT 365926 B AT365926 B AT 365926B AT 0363479 A AT0363479 A AT 0363479A AT 363479 A AT363479 A AT 363479A AT 365926 B AT365926 B AT 365926B
Authority
AT
Austria
Prior art keywords
prostacycline
stabilizing
compounds
pharmacologically active
formulations
Prior art date
Application number
AT0363479A
Other languages
English (en)
Other versions
ATA363479A (de
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ATA363479A publication Critical patent/ATA363479A/de
Application granted granted Critical
Publication of AT365926B publication Critical patent/AT365926B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT0363479A 1978-05-17 1979-05-16 Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen AT365926B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2017578 1978-05-17

Publications (2)

Publication Number Publication Date
ATA363479A ATA363479A (de) 1981-07-15
AT365926B true AT365926B (de) 1982-02-25

Family

ID=10141640

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0363479A AT365926B (de) 1978-05-17 1979-05-16 Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen
AT79101516T ATE4411T1 (de) 1978-05-17 1979-05-17 Prostaglandin-verbindungen enthaltende pharmazeutische praeparate und verfahren zu deren herstellung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT79101516T ATE4411T1 (de) 1978-05-17 1979-05-17 Prostaglandin-verbindungen enthaltende pharmazeutische praeparate und verfahren zu deren herstellung.

Country Status (28)

Country Link
US (1) US4335139A (de)
EP (1) EP0005768B1 (de)
JP (1) JPS54163809A (de)
KR (1) KR830000527B1 (de)
AT (2) AT365926B (de)
AU (1) AU525695B2 (de)
BE (1) BE876296A (de)
CA (1) CA1141661A (de)
CH (1) CH641044A5 (de)
CS (1) CS214798B2 (de)
DE (2) DE2966046D1 (de)
DK (1) DK156004C (de)
ES (1) ES480597A1 (de)
FI (1) FI68359C (de)
FR (1) FR2425856A1 (de)
GR (1) GR68452B (de)
HU (1) HU182746B (de)
IL (1) IL57298A (de)
IT (1) IT1116840B (de)
LU (1) LU81272A1 (de)
MC (1) MC1265A1 (de)
NL (1) NL7903871A (de)
NZ (1) NZ190462A (de)
PH (1) PH15850A (de)
PL (1) PL134004B1 (de)
SE (1) SE450930B (de)
SU (1) SU978715A3 (de)
ZA (1) ZA787353B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010002A1 (de) * 1980-03-15 1981-10-01 Hoechst Ag, 6000 Frankfurt Prostaglandine enthaltende pharmazeutische zubereitung
EP0347243B1 (de) * 1988-06-17 1993-01-13 The Wellcome Foundation Limited Prostaglandinanaloge zur Verwendung in der Medizin
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
JP3421330B2 (ja) * 2000-11-02 2003-06-30 持田製薬株式会社 ビダラビン注射用乾燥製剤
EP1238670A1 (de) * 2001-03-07 2002-09-11 Bruce Daniels Zusammensetzungen zur Behandlung und Verhütung von Gefässerkrankungen und Hypertonie
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
DE602006005423D1 (de) * 2005-06-29 2009-04-16 Verisfield Uk Ltd Pharmazeutische Zusammensetzungen von Risperidon in wässriger Lösung
WO2007092343A2 (en) * 2006-02-03 2007-08-16 Scidose Llc Novel epoprostenol formulation and method of making thereof
JP2010538092A (ja) * 2007-09-07 2010-12-09 ユナイテッド セラピューティクス コーポレーション グラム陰性菌に対して選択的殺菌活性を有するバッファー溶液およびそれを使用する方法
HU231031B1 (hu) 2016-03-23 2019-12-30 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Megnövelt stabilitású epoprostenol nátrium és eljárás előállítására
DE202024100435U1 (de) 2023-02-14 2024-02-22 Tomasz Dąbrowski Zaunfeld zum Aufbau einer Reitbande

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036954A (en) 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
GB1504437A (en) 1974-03-08 1978-03-22 Dunlop Ltd Rubberplastics composites
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
US3997587A (en) 1975-06-26 1976-12-14 Syntex (U.S.A.) Inc. D1- and 8R-9-fluoro-prostadienoic acid derivatives
US4005133A (en) 1975-10-14 1977-01-25 The Upjohn Company PGF2.sub.α, L-Arginine salt
FR2351112A1 (fr) * 1975-10-21 1977-12-09 Wellcome Found Derive de prostaglandine et medicament contenant ce derive
US4062964A (en) 1975-12-03 1977-12-13 Ciba-Geigy Corporation Antifertility-combinations
GB1583961A (en) * 1976-05-11 1981-02-04 Wellcome Found Prostacyclin and derivatives thereof
NL7805402A (nl) * 1977-05-20 1978-11-22 Wellcome Found Werkwijze voor de geneeskundige toepassing van prosta- cycline of zijn dihydroderivaat in combinatie met een fosfodiesterase-inhibitor.

Also Published As

Publication number Publication date
MC1265A1 (fr) 1980-03-28
GR68452B (de) 1981-12-30
DE2920020A1 (de) 1979-11-29
ES480597A1 (es) 1980-08-16
US4335139A (en) 1982-06-15
FI791565A (fi) 1979-11-18
IT1116840B (it) 1986-02-10
SE450930B (sv) 1987-08-17
DK201879A (da) 1979-11-18
IL57298A0 (en) 1979-09-30
ZA787353B (en) 1980-08-27
LU81272A1 (fr) 1979-12-07
AU525695B2 (en) 1982-11-25
BE876296A (fr) 1979-11-16
SU978715A3 (ru) 1982-11-30
AU4704279A (en) 1979-11-22
JPS54163809A (en) 1979-12-26
IL57298A (en) 1983-09-30
KR830000527B1 (ko) 1983-03-12
PL215627A1 (de) 1981-08-07
CH641044A5 (de) 1984-02-15
DK156004B (da) 1989-06-12
FI68359C (fi) 1985-09-10
CS214798B2 (en) 1982-05-28
PL134004B1 (en) 1985-07-31
FI68359B (fi) 1985-05-31
PH15850A (en) 1983-04-13
ATE4411T1 (de) 1983-08-15
IT7949064A0 (it) 1979-05-16
ATA363479A (de) 1981-07-15
EP0005768B1 (de) 1983-08-10
JPS6358810B2 (de) 1988-11-17
EP0005768A1 (de) 1979-12-12
NZ190462A (en) 1982-05-31
DE2920020C2 (de) 1988-09-01
CA1141661A (en) 1983-02-22
HU182746B (en) 1984-03-28
FR2425856B1 (de) 1982-06-25
FR2425856A1 (fr) 1979-12-14
SE7904284L (sv) 1979-11-18
DE2966046D1 (en) 1983-09-15
NL7903871A (nl) 1979-11-20
DK156004C (da) 1989-11-06

Similar Documents

Publication Publication Date Title
NO160850C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(bicykliske heterocyklyl)-4-piperidinaminer.
DK151623C (da) Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
SE8403487D0 (sv) Farmaceutisk komposition
ATE109971T1 (de) Verabreichung von arzneimitteln über die lungen.
NO830618L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive 3-hydroksybutansyreforbindelser
DK529888A (da) Substituerede n-(1-alkyl-3-hydroxy-4-piperidinyl) benzamider
AT365926B (de) Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen
NO179359C (no) Fremgangsmåte for fremstilling av farmasöytisk preparat inneholdende somatostatinanaloger.
FI94354C (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
JPS5753414A (en) Stabilized medicinal composition
IT7924028A0 (it) Uso di acidi arilamino benzoici come agenti ipoglicemizzanti e composizioni farmaceutiche per detto uso.
IT8620208A0 (it) Eteri del 7-ossabicicloeptano sostituiti quali analoghi di prostaglandine e relative composizioni farmaceutiche.
DK161833C (da) Analogifremgangsmaade til fremstilling af n-(vinblastinoyl-23)-derivater af aminosyrer eller farmaceutisk acceptable syreadditionssalte deraf
IT1055787B (it) Procedimento di preparazione dell amino 4 fenil 2 amino 5 benzimidazolo
SE7807225L (sv) Sett att framstella 4-hydroxicinnolin-derivat
AT344885B (de) Verfahren zur herstellung von 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxy-4,16,32,34,36-pentamethyl-tetrakonta-16,32-dien-35-o-lacton-40-guanidiniumsulfat(debrycin) enthaltenden pharmazeutischen praeparaten
ES535408A0 (es) Un metodo de producir una composicion farmaceutica que contiene isoxicamato de l-arginina como ingrediente activo.
JPS51136602A (en) Process for preparation of amino acid or peptide
DK149272C (da) Analogifremgangsmaade til fremstilling af lhrh-analoge nona- eller decapeptider eller farmaceutisk anvendelige syreadditionssalte deraf
PT76756A (de) Verfahren zur herstellung von 5z-formen von 2,3,4-trinor-1,5-inter-m-phenylenprostacyclinderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELA Expired due to lapse of time